Awareness of biomarker test timing and purpose in patients with non-small cell lung cancer (NSCLC).

Authors

null

Nisha Anjali Mohindra

Department of Medicine, Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL

Nisha Anjali Mohindra, Julia R. Trosman, Stefanie Houseknecht, Josephine Louella Feliciano, Ruth Lauren Sacks, Benjamin Souter, Wendi Waugh, Jeremiah Martin, Jennifer Woodyard, Laura Schmidt, Cara Chang, Anna Rediske, Sonia Zavala, Thomas William Lycan, Nikki A. Martin, Ashley Lile, Leigh Boehmer, Christine B. Weldon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B

Track

Health Care Access, Equity, and Disparities,Technology and Innovation in Quality of Care,Palliative and Supportive Care

Sub Track

Access to Treatment

Citation

JCO Oncol Pract 19, 2023 (suppl 11; abstr 138)

DOI

10.1200/OP.2023.19.11_suppl.138

Abstract #

138

Poster Bd #

C15

Abstract Disclosures

Similar Posters

First Author: Julia R. Trosman

First Author: Muzammil Dastagir

Poster

2023 ASCO Quality Care Symposium

Mutation-specific costs of advanced non-small cell lung cancer treatment.

Mutation-specific costs of advanced non-small cell lung cancer treatment.

First Author: Juanyi Tan